Role of the transcriptional factor C/EBPbeta in free fatty acid-elicited beta-cell failure

Mol Cell Endocrinol. 2009 Jun 16;305(1-2):47-55. doi: 10.1016/j.mce.2008.12.005. Epub 2008 Dec 24.

Abstract

Fatty acids can favour the development of Type 2 diabetes by reducing insulin secretion and inducing apoptosis of pancreatic beta-cells. Here, we show that sustained exposure of the beta-cell line MIN6 or of isolated pancreatic islets to the most abundant circulating fatty acid palmitate increases the level of C/EBPbeta, an insulin transcriptional repressor. In contrast, two unsaturated fatty acids, oleate and linoleate were without effect. The induction of C/EBPbeta elicited by palmitate was prevented by inhibiting the ERK1/2 MAP kinase pathway or by reducing mitochondrial fatty acid oxidation with an inhibitor of Carnitine Palmitoyl Transferase-1. Overexpression of C/EBPbeta mimicked the detrimental effects of palmitate and resulted in a drastic reduction in insulin promoter activity, impairment in the capacity to respond to secretory stimuli and an increase in apoptosis. Our data suggest a potential involvement of C/EBPbeta as mediator of the deleterious effects of unsaturated free fatty acids on beta-cell function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects*
  • CCAAT-Enhancer-Binding Protein-beta / genetics
  • CCAAT-Enhancer-Binding Protein-beta / metabolism
  • CCAAT-Enhancer-Binding Protein-beta / physiology*
  • Carnitine O-Palmitoyltransferase / pharmacology
  • Cell Line
  • Insulin / biosynthesis
  • Insulin-Secreting Cells / cytology
  • Insulin-Secreting Cells / drug effects*
  • Linoleic Acid / pharmacology
  • MAP Kinase Signaling System / drug effects
  • Oleic Acid / pharmacology
  • Oxidation-Reduction
  • Palmitates / pharmacology*

Substances

  • CCAAT-Enhancer-Binding Protein-beta
  • Insulin
  • Palmitates
  • Oleic Acid
  • Linoleic Acid
  • Carnitine O-Palmitoyltransferase